Response to Pembrolizumab in a Patient With Chemotherapy Refractory Bladder Cancer With Small Cell Variant Histology: A Case Report and Review of the Literature

Lindsay Wilde; Siraj M. Ali; Charalambos C. Solomides; Jeffrey S. Ross; Edouard Trabulsi; Jean Hoffman-Censits

doi:10.1016/j.clgc.2016.12.012

Response to Pembrolizumab in a Patient With Chemotherapy Refractory Bladder Cancer With Small Cell Variant Histology: A Case Report and Review of the Literature

Lindsay Wilde, Siraj M. Ali, Charalambos C. Solomides, Jeffrey S. Ross, Edouard Trabulsi, Jean Hoffman-Censits

School of Medicine

Research output: Contribution to journal › Article

Original language	English (US)
Pages (from-to)	e521-e524
Journal	Clinical Genitourinary Cancer
Volume	15
Issue number	3
DOIs	https://doi.org/10.1016/j.clgc.2016.12.012
State	Published - Jun 2017

Keywords

Genomic profiling
Immunotherapy
PD-1 inhibitor
Small-cell carcinoma of the bladder
Variant histology

ASJC Scopus subject areas

Oncology
Urology

Access to Document

10.1016/j.clgc.2016.12.012

Cite this

Wilde, L., Ali, S. M., Solomides, C. C., Ross, J. S., Trabulsi, E., & Hoffman-Censits, J. (2017). Response to Pembrolizumab in a Patient With Chemotherapy Refractory Bladder Cancer With Small Cell Variant Histology: A Case Report and Review of the Literature. Clinical Genitourinary Cancer, 15(3), e521-e524. https://doi.org/10.1016/j.clgc.2016.12.012

Response to Pembrolizumab in a Patient With Chemotherapy Refractory Bladder Cancer With Small Cell Variant Histology : A Case Report and Review of the Literature. / Wilde, Lindsay; Ali, Siraj M.; Solomides, Charalambos C.; Ross, Jeffrey S.; Trabulsi, Edouard; Hoffman-Censits, Jean.

In: Clinical Genitourinary Cancer, Vol. 15, No. 3, 06.2017, p. e521-e524.

Research output: Contribution to journal › Article

@article{fd9b3874a171485eb3635f6de3022563,

title = "Response to Pembrolizumab in a Patient With Chemotherapy Refractory Bladder Cancer With Small Cell Variant Histology: A Case Report and Review of the Literature",

keywords = "Genomic profiling, Immunotherapy, PD-1 inhibitor, Small-cell carcinoma of the bladder, Variant histology",

author = "Lindsay Wilde and Ali, {Siraj M.} and Solomides, {Charalambos C.} and Ross, {Jeffrey S.} and Edouard Trabulsi and Jean Hoffman-Censits",

year = "2017",

month = jun,

doi = "10.1016/j.clgc.2016.12.012",

language = "English (US)",

volume = "15",

pages = "e521--e524",

journal = "Clinical Genitourinary Cancer",

issn = "1558-7673",

publisher = "Elsevier",

number = "3",

}

TY - JOUR

T1 - Response to Pembrolizumab in a Patient With Chemotherapy Refractory Bladder Cancer With Small Cell Variant Histology

T2 - A Case Report and Review of the Literature

AU - Wilde, Lindsay

AU - Ali, Siraj M.

AU - Solomides, Charalambos C.

AU - Ross, Jeffrey S.

AU - Trabulsi, Edouard

AU - Hoffman-Censits, Jean

PY - 2017/6

Y1 - 2017/6

KW - Genomic profiling

KW - Immunotherapy

KW - PD-1 inhibitor

KW - Small-cell carcinoma of the bladder

KW - Variant histology

UR - http://www.scopus.com/inward/record.url?scp=85010951298&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85010951298&partnerID=8YFLogxK

U2 - 10.1016/j.clgc.2016.12.012

DO - 10.1016/j.clgc.2016.12.012

M3 - Article

C2 - 28143711

AN - SCOPUS:85010951298

VL - 15

SP - e521-e524

JO - Clinical Genitourinary Cancer

JF - Clinical Genitourinary Cancer

SN - 1558-7673

IS - 3

ER -